Soleo earns specialty accreditation
By HME News Staff
Updated 10:21 AM CST, Tue February 1, 2022
FRISCO, Texas – Soleo Health has achieved accreditation through the Accreditation Commission for Health Care as a specialty pharmacy with distinction in rare disease and orphan drugs. It’s one of only six nationally to earn the distinction. “Soleo Health prides itself on delivering the highest quality care and bringing innovative specialty pharmaceuticals to patients,” said Drew Walk, Soleo Health's CEO. “This accreditation is indicative of our abilities to consistently strive to exceed the expectations of our stakeholders, including patients, providers, manufacturers and payers. We are honored to be recognized by the ACHC with this prominent distinction, which demonstrates our unrelenting commitment to care.” Soleo Health’s locations in Chicago, Philadelphia, Phoenix and Columbus, Ohio, which each have a national reach through the company’s licensure in all 50 states, have earned the accreditation. The process involved audits of Soleo Health’s policies and procedures, compliance checks and analysis of training tools, as well as evaluation of patient protocols and delivery of care processes.
Comments